Trials / Unknown
UnknownNCT04923607
Phase I Clinical Trial of TQC2731 Injection
A Phase I, Randomized, Double-Blind, Placebo-Controlled Study of TQC2731 Injection in Healthy Adult Subjects and Patients With Severe Asthma
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 96 (estimated)
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
This is the first-in-human phase 1 trial of TQC2731 injection in healthy subjects and in patients with severe asthma to evaluate the safety, tolerability, pharmacokinetic characteristics and immunogenicity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TQC2731 | TQC2731 injection |
| DRUG | Placebo | Matching placebo with no active ingredients |
Timeline
- Start date
- 2021-06-25
- Primary completion
- 2023-08-25
- Completion
- 2023-08-25
- First posted
- 2021-06-11
- Last updated
- 2021-06-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04923607. Inclusion in this directory is not an endorsement.